Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Similar articles for PubMed (Select 24565904)

1.

The synthesis of 4,7-disubstituted-2H-benzo[b][1,4]-oxazin-3(4H)-ones using Smiles rearrangement and their in vitro evaluation as platelet aggregation inhibitors.

Xia S, Liu JQ, Wang XH, Tian Y, Wang Y, Wang JH, Fang L, Zuo H.

Bioorg Med Chem Lett. 2014 Mar 15;24(6):1479-83. doi: 10.1016/j.bmcl.2014.02.014. Epub 2014 Feb 14.

PMID:
24565904
2.

Synthesis of 2H-benzo[b][1,4]oxazin-3(4H)-one derivatives as platelet aggregation inhibitors.

Tian X, Wang LY, Xia S, Li ZB, Liu XH, Yuan Y, Fang L, Zuo H.

Bioorg Med Chem Lett. 2012 Jan 1;22(1):204-6. doi: 10.1016/j.bmcl.2011.11.027. Epub 2011 Nov 16.

PMID:
22137848
3.
4.
5.

Fluorinated dual antithrombotic compounds based on 1,4-benzoxazine scaffold.

Ilić M, Kikelj D, Ilaš J.

Eur J Med Chem. 2012 Apr;50:255-63. doi: 10.1016/j.ejmech.2012.01.059. Epub 2012 Feb 8.

PMID:
22365562
6.

Design and synthesis of novel platelet fibrinogen receptor antagonists with 2H-1,4-benzoxazine-3(4H)-one scaffold. A systematic study.

Anderluh M, Cesar J, Stefanic P, Kikelj D, Janes D, Murn J, Nadrah K, Tominc M, Addicks E, Giannis A, Stegnar M, Dolenc MS.

Eur J Med Chem. 2005 Jan;40(1):25-49.

PMID:
15642407
7.
8.

1,4-Benzoxazine-3(4H)-ones as potent inhibitors of platelet aggregation: design, synthesis and structure-activity relations.

Liu C, Tan JL, Xiao SY, Liao JF, Zou GR, Ai XX, Chen JB, Xiang Y, Yang Q, Zuo H.

Chem Pharm Bull (Tokyo). 2014;62(9):915-20. Epub 2014 Jul 9.

9.

New platelet fibrinogen receptor glycoprotein IIb-IIIa antagonists: orally active series of N-alkylated amidines with a 6,6-bicyclic template.

Okumura K, Shimazaki T, Aoki Y, Yamashita H, Tanaka E, Banba S, Yazawa K, Kibayashi K, Banno H.

J Med Chem. 1998 Oct 8;41(21):4036-52.

PMID:
9767641
10.
11.

Use of conformationally restricted benzamidines as arginine surrogates in the design of platelet GPIIb-IIIa receptor antagonists.

Sall DJ, Arfsten AE, Bastian JA, Denney ML, Harms CS, McCowan JR, Morin JM Jr, Rose JW, Scarborough RM, Smyth MS, Um SL, Utterback BG, Vasileff RT, Wikel JH, Wyss VL, Jakubowski JA.

J Med Chem. 1997 Aug 29;40(18):2843-57.

PMID:
9288166
12.

Novel 1,4-benzoxazine and 1,4-benzodioxine inhibitors of angiogenesis.

Ilić M, Ilaš J, Dunkel P, Mátyus P, Boháč A, Liekens S, Kikelj D.

Eur J Med Chem. 2012 Dec;58:160-70. doi: 10.1016/j.ejmech.2012.10.001. Epub 2012 Oct 8.

PMID:
23124213
13.

Orally active GPIIb/IIIa antagonists: synthesis and biological activities of masked amidines as prodrugs of 2-[(3S)-4.

Kitamura S, Fukushi I, Miyawaki T, Kawamura M, Terashita E, Naka T.

Chem Pharm Bull (Tokyo). 2001 Mar;49(3):268-77.

14.

Potent dibasic GPIIb/IIIa antagonists with reduced prolongation of bleeding time: synthesis and pharmacological evaluation of 2-oxopiperazine derivatives.

Kitamura S, Fukushi H, Miyawaki T, Kawamura M, Konishi N, Terashita Z, Naka T.

J Med Chem. 2001 Jul 19;44(15):2438-50.

PMID:
11448226
15.

Design and synthesis of an orally active GPIIb/IIIa antagonist based on a phenylpiperazine scaffold.

van Maarseveen JH, den Hartog JA, Tipker K, Reinders JH, Brakkee J, Schön U, Kehrbach W, Kruse CG.

Bioorg Med Chem Lett. 1998 Jun 16;8(12):1531-6.

PMID:
9873384
16.

Discovery and structure--activity relationship studies of a novel and specific peptide motif, Pro-X-X-X-Asp-X, as a platelet fibrinogen receptor antagonist.

Hayashi Y, Katada J, Sato Y, Igarashi K, Takiguchi Y, Harada T, Muramatsu M, Yasuda E, Uno I.

Bioorg Med Chem. 1998 Mar;6(3):355-64.

PMID:
9568289
17.

Non-peptide GPIIb/IIIa inhibitors. 20. Centrally constrained thienothiophene alpha-sulfonamides are potent, long acting in vivo inhibitors of platelet aggregation.

Egbertson MS, Cook JJ, Bednar B, Prugh JD, Bednar RA, Gaul SL, Gould RJ, Hartman GD, Homnick CF, Holahan MA, Libby LA, Lynch JJ Jr, Lynch RJ, Sitko GR, Stranieri MT, Vassallo LM.

J Med Chem. 1999 Jul 1;42(13):2409-21. Erratum in: J Med Chem 1999 Sep 23;42(19):4014.

PMID:
10395482
18.

Platelet glycoprotein IIb/IIIa receptor antagonists derived from isoxazolidines.

Confalone PN, Jin F, Mousa SA.

Bioorg Med Chem Lett. 1999 Jan 4;9(1):55-8.

PMID:
9990456
19.

3,4-Dihydro-2H-1,4-benzoxazine derivatives combining thrombin inhibitory and glycoprotein IIb/IIIa receptor antagonistic activity as a novel class of antithrombotic compounds with dual function.

Ilas J, Jakopin Z, Borstnar T, Stegnar M, Kikelj D.

J Med Chem. 2008 Sep 25;51(18):5617-29. doi: 10.1021/jm8003448. Epub 2008 Aug 27.

PMID:
18729445
20.

Preparation and biological activity of novel tricyclic GPIIb/IIIa antagonists.

Robarge KD, Dina MS, Somers TC, Lee A, Rawson TE, Olivero AG, Tischler MH, Webb RR 2nd, Weese KJ, Aliagas I, Blackburn BK.

Bioorg Med Chem. 1998 Dec;6(12):2345-81.

PMID:
9925295
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk